TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ADAG

Adagene Inc

Healthcare · Biotechnology

3.20$ +9.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

Adagene Inc (ADAG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -16 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ADAG
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-14 -18 -29 -43 -49 -28 -30 -16
0.9 0.8 0.9 1.1 1.4 1.2 0.9 0.6
0.1 0.6 10 19 11 7.3 4.9 3.7
-0.4 -0.6 11 19 – – – –
0.5 -1.9 2.2 9.3 22 -17 -1.9 -0.8
0.5 0.2 0.9 2.5 0.7 0.1 0.0 0.0
-30 25 7.1 -2.5 -0.7 -0.1 1.1 0.5
– – – 4.6 0.3 – – –
– – 0.0 -2.4 -4.0 0.0 0.0 –
1.1 0.2 5.0 -0.7 21 -5.4 -3.4 -12
51 70 4.4 145 18 -5.4 3.8 4.4
7.3 76 -17 99 -31 -34 -25 -11
-15 -18 -29 -46 -49 -29 -30 -16

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?